new
   What are the Indications for Roflumilast Tablets (Daxas)?
502
Jan 26, 2026

Roflumilast Tablets (Daxas) are a selective phosphodiesterase 4 (PDE4) inhibitor, primarily indicated for the treatment of chronic obstructive pulmonary disease (COPD).

What are the Indications for Roflumilast Tablets (Daxas)?

Core Indications

This medication is indicated for adult patients with severe COPD who have a history of acute exacerbations and are diagnosed with chronic bronchitis.

As a long-term treatment, it is used to reduce the frequency of future COPD acute exacerbations (e.g., sudden worsening of symptoms, which usually requires the use of systemic glucocorticoids or antibiotics, and even hospitalization).

Usage Limitations and Important Notes

Roflumilast Tablets are not bronchodilators and should not be used for relieving acute bronchospasm or treating sudden onset of dyspnea.

Patients must keep other emergency medications (e.g., short-acting bronchodilators) as prescribed by physicians for the management of acute symptom attacks.

Specifications and Properties of Roflumilast Tablets (Daxas)

Specifications

250 mcg tablets: Each tablet contains 250 mcg of roflumilast.

500 mcg tablets: Each tablet contains 500 mcg of roflumilast. This is the recommended maintenance dose.

Properties

Scoring and Markings: One side of the tablet is embossed with the letter "D", and the other side is embossed with the corresponding dosage numbers "250" or "500".

Active Ingredient: The main active ingredient of each tablet is roflumilast.

Excipient Ingredients: Including lactose monohydrate, corn starch, povidone and magnesium stearate. It is contraindicated in patients with hypersensitivity to any of these ingredients.

Storage and Handling Methods for Roflumilast Tablets (Daxas)

Storage Conditions

Temperature Requirement: Roflumilast Tablets should be stored at room temperature between 20°C and 25°C (68°F and 77°F).

Allowable Temperature Fluctuation Range: For short periods, temperatures may fluctuate between 15°C and 30°C (59°F and 86°F). This complies with the United States Pharmacopeia (USP) requirements for "controlled room temperature" storage.

Environmental Requirement: Store in a cool and dry place, away from direct sunlight, moisture and excessive heat (e.g., bathrooms, near kitchen stoves or inside vehicles).

Safe Handling

Child Safety: All medications must be kept out of the reach and sight of children to prevent accidental ingestion.

Storage in Original Packaging: It is recommended to keep the tablets in their original packaging (e.g., aluminum foil blisters or medicine bottles) until administration. This helps protect against moisture and light exposure, and preserves medication identification information.

Disposal of Expired Medications: Do not use expired medications. Unwanted or expired tablets should be disposed of in accordance with local regulations for pharmaceutical waste, and should not be discarded in household garbage or flushed down the drain.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Roflumilast(Daxas)
To reduce the risk of exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
RELATED ARTICLES
Adverse Reactions of Roflumilast Tablets (Daxas)

Roflumilast Tablets (Daxas) is a selective phosphodiesterase 4 (PDE4) inhibitor. It is indicated for patients with...

Tuesday, January 27th, 2026, 11:38
What are the Precautions for Taking Roflumilast Tablets (Daxas)?

Roflumilast Tablets (Daxas) are a selective phosphodiesterase 4 inhibitor, primarily indicated for reducing the risk...

Tuesday, January 27th, 2026, 11:35
Dosage and Administration, Recommended Dosage of Roflumilast Tablets (Daxas)

Roflumilast Tablets (Daxas) are a selective phosphodiesterase 4 (PDE4) inhibitor, primarily indicated for reducing...

Monday, January 26th, 2026, 11:58
What are the Indications for Roflumilast Tablets (Daxas)?

Roflumilast Tablets (Daxas) are a selective phosphodiesterase 4 (PDE4) inhibitor, primarily indicated for the...

Monday, January 26th, 2026, 11:54
RELATED MEDICATIONS
Roflumilast
To reduce the risk of exacerbations in patients with severe COPD associated...
TOP
1
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved